Gerald Downey
Impact in
- Oncology top 10%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Cutaneous Melanoma Detection and Management
-
- Immunotherapy and Immune Responses
Papers in
-
- HIV/AIDS drug development and treatment 4
- Oncology 4
- CAR-T cell therapy research 2
- Colorectal Cancer Treatments and Studies 2
- Co-authors
- Kevin J. Harrington (3 shared papers)Robert H.I. Andtbacka (2 shared papers)Frances A. Collichio (2 shared papers)Howard L. Kaufman (2 shared papers)Katarina Öhrling (3 shared papers)Mark R. Middleton (1 shared paper)Emanuela Palmerini (1 shared paper)Peter Reichardt (1 shared paper)
- Journals
- Pharmacoepidemiology and Drug Safety (3 papers)Tropical Medicine & International Health (2 papers)AIDS (2 papers)Journal for ImmunoTherapy of Cancer (1 paper)European Journal of Dermatology (1 paper)
- Partner nations
- United KingdomUnited StatesSwitzerland
In The Last Decade
Gerald Downey
19 papers receiving 901 citations
Gerald Downey's Hit Papers
Peers
Comparison fields: 5 of 85
- Oncology 377
- Immunology 183
- Virology 39
- Genetics 224
- Rheumatology 96
Countries citing papers authored by Gerald Downey
This map shows the geographic impact of Gerald Downey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerald Downey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerald Downey more than expected).
Fields of papers citing papers by Gerald Downey
This network shows the impact of papers produced by Gerald Downey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerald Downey. The network helps show where Gerald Downey may publish in the future.
Co-authors
The 25 scholars most cited alongside Gerald Downey, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Final analyses of OPTiM: a randomized phase III trial of talimogene laherparepvec versus granulocyte-macrophage colony-stimulating factor in unresectable stage III–IV melanoma Hit paper breakdown → | 2019 | 326 |
| 2 | 2019 | 103 | |
| 3 | 2004 | 88 | |
| 4 | 2016 | 83 | |
| 5 | 2016 | 57 | |
| 6 | 2004 | 49 | |
| 7 | 2005 | 49 | |
| 8 | 2017 | 33 | |
| 9 | 2015 | 21 | |
| 10 | 2017 | 21 | |
| 11 | 2018 | 19 | |
| 12 | 2006 | 18 | |
| 13 | 2016 | 14 | |
| 14 | IMI-PROTECT benefit-risk grouprecommendations report:recommendations for the methodology andvisualisation techniques to be used in theassessment of benefit and risk of medicines | 2014 | 14 |
| 15 | 2008 | 11 | |
| 16 | 2018 | 10 | |
| 17 | 2015 | 7 | |
| 18 | 2017 | 6 | |
| 19 | 2003 | 4 |
About Gerald Downey
Gerald Downey is a scholar working on Infectious Diseases, Oncology, Public Health, Environmental and Occupational Health, Genetics and Plant Science, having authored 19 papers that have together received 933 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (4 papers), Mosquito-borne diseases and control (2 papers), Insect Pest Control Strategies (2 papers), Malaria Research and Control (2 papers), Virus-based gene therapy research (2 papers), CAR-T cell therapy research (2 papers), Colorectal Cancer Treatments and Studies (2 papers) and Viral Infectious Diseases and Gene Expression in Insects (1 paper). The work is most often cited by research in Oncology (377 citations), Immunology (183 citations), Virology (39 citations), Genetics (224 citations) and Rheumatology (96 citations). Gerald Downey has collaborated with scholars based in United Kingdom, United States and Switzerland. Frequent co-authors include Kevin J. Harrington, Robert H.I. Andtbacka, Frances A. Collichio, Howard L. Kaufman, Katarina Öhrling, Mark R. Middleton, Emanuela Palmerini, Peter Reichardt, Piero Picci and Mark Rowland. Their work appears in journals such as Pharmacoepidemiology and Drug Safety, Tropical Medicine & International Health, AIDS, Journal for ImmunoTherapy of Cancer and European Journal of Dermatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.